AB 432: Menopause.

Official summary

Legislative Counsel’s Digest (official, as of the latest version). Written by nonpartisan legislative staff; reproduced verbatim.

(1)Existing law, the Medical Practice Act, provides for the licensure and regulation of physicians and surgeons by the Medical Board of California and requires the board to adopt and administer standards for the continuing education of those licensees. Existing law requires the board, in determining its continuing education requirements, to consider including a course in menopausal mental or physical health.

This bill would delete that requirement of the board. The bill would require, beginning July 1, 2026, and until July 1, 2032, a qualifying physician and surgeon, as defined, who completes continuing medical education courses in perimenopause, menopause, and postmenopausal care to receive 2 hours of credit for each hour completed of that coursework, as specified.

Existing law, the Osteopathic Act, provides for the licensure and regulation of osteopathic physicians and surgeons by the Osteopathic Medical Board of California and requires the board to adopt and administer standards for the continuing education of those licensees.

This bill would require osteopathic physicians and surgeons to receive the same credit as described above for completed coursework relating to perimenopause, menopause, and postmenopausal care.

(2)Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care and makes a willful violation of the act a crime. Existing law also provides for the regulation of health insurers by the Department of Insurance. Existing law sets forth specified coverage requirements for health care service plan contracts and health insurance policies.

This bill would require a health care service plan contract or health insurance policy that covers outpatient prescription drugs, except as specified, that is issued, amended, or renewed on or after January 1, 2026, to include coverage for evaluation and treatment options for symptoms of perimenopause and menopause. The bill would require a health care service plan or health insurer to annually provide clinical care recommendations, as specified, for hormone therapy to all contracted primary care providers who treat individuals with perimenopause and menopause. Because a willful violation of these provisions by a health care service plan would be a crime, the bill would impose a state-mandated local program.

Sponsors

Sponsors by party (alphabetical): Democratic 9

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

1. January 22, 2026Consideration of Governor's veto stricken from file.
2. October 13, 2025Consideration of Governor's veto pending.
3. October 13, 2025Vetoed by Governor.
4. September 22, 2025Enrolled and presented to the Governor at 3 p.m.
5. September 10, 2025Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 77. Noes 1. Page 3224.).
6. September 9, 2025In Assembly. Concurrence in Senate amendments pending.
7. September 9, 2025Read third time. Passed. Ordered to the Assembly. (Ayes 39. Noes 0. Page 2748.).
8. September 8, 2025Read second time. Ordered to third reading.
9. September 5, 2025Read third time and amended. Ordered to second reading.
10. September 2, 2025Read second time. Ordered to third reading.
11. August 29, 2025Read second time and amended. Ordered returned to second reading.
12. August 29, 2025From committee: Amend, and do pass as amended. (Ayes 7. Noes 0.) (August 29).